Table 1 (abstract O09). Comparison of clinical parameters and SLICC-SDI scores following MMF vs CYC treatment
From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
Time post biopsy* | Outcome parameter | MMF induction | CYC induction | p |
|---|---|---|---|---|
10-14 | Renal BILAG score | A=1, B=5, C=3, D=18 | A=1, B=3, C=2, D=8 | 1.00 |
UACR** | 13[4-42] | 21[3–56] | 0.99 | |
Serum creatinine | 59[51-69] | 62[50-73] | 0.32 | |
ESR | 12[5–21] | 20[4–49] | 0.62 | |
dsDNA | 44[24-95] | 20[6-440] | 0.84 | |
C3 | 0.98[0.81-1.18] | 1.04[0.92–1.34] | 0.20 | |
Patient global | 4.5[0–9.3] | 3.0[0.5–52.0] | 0.98 | |
Physician global | 7.0[1.3–14.0] | 9.9[3.0–24.0] | 0.66 | |
13*** | SLICC SDI | 0[0-1] | 0[0–2.5] | 0.67 |